Nanobiotix is trading 5% down today at $38.16 on light, news-less weakness despite a positive biotech tape.
- The move stands out against a roughly 2% gain in the broader biotech sector and mixed major indices.
- With no fresh company headlines or analyst calls, the decline suggests short-term profit taking or position adjustment rather than a clear fundamental catalyst.